Focus Diagnostics, Cypress, Calif, will incorporate proprietary and novel probe technology from Evogen Inc, Lenexa, Kan, into its molecular diagnostic products and services.
Evogen’s HyBeacons® PCR probes are sequence-specific hybridization probes containing two fluorophores per probe, creating a robust fluorescent signal.
Since the probes are not hydrolyzed during PCR amplification, positive confirmation of the amplicon is available by way of high-definition melt curve analysis.
HyBeacons are easy to design, which offers the ability to multiplex different color probes for the identification of multiple targets in a single reaction.They provide clear quantitative data during amplification and have proven capabilities with DNA and RNA targets.
Focus Diagnostics develops and manufactures the Simplexa line of molecular test products, operating on the 3M Integrated Cycler, for aiding in the diagnosis of influenza, Clostridium difficile, Epstein Barr, and other diseases.
[Source: Evogen]
